Home
Conditions
Neoplasms, Connective and Soft Tissue

Clinical trial condition

Neoplasms, Connective and Soft Tissue

Explore clinical trials studying Neoplasms, Connective and Soft Tissue. Study availability and eligibility vary by location and protocol.

2,728 public trials 585 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Connective and Soft Tissue trial results

Completed

Intrauterine Adhesion Rate After Hysteroscopic Myomectomy and Application of HYALOBARRIER Gel

NCT01412489

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +8 more
Locations: Service de Gynecologie-Obstetrique, Hopital Lariboisière Paris, France

View Trial Details

Completed

Biologic Predictors of Leiomyoma Treatment Outcomes

NCT01936493

Conditions: Connective Tissue Diseases, Fibroids, Leiomyoma, +11 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma

NCT01537744

Conditions: Liposarcoma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Sidney Kimmel Cancer Center @ Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma

NCT00365872

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

Collagenase Option for Reduction of Dupuytren's Contracture in Japan

NCT01588353

Conditions: Connective Tissue Diseases, Contracture, Dupuytren Contracture, +10 more
Locations: Aichi, Japan

Aomori, Japan

Chiba, Japan

Fukuoka, Japan

View all 20 locations

View Trial Details

Completed

Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib

NCT01831726

Conditions: Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +47 more
Locations: Alabama Oncology Birmingham, Alabama, United States

Highlands Oncology Group SC Fayetteville, Arkansas, United States

PCR Oncology Pismo Beach, California, United States

Sarcoma Oncology Center Santa Monica, California, United States

View all 49 locations

View Trial Details

Completed

A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB

NCT01125800

Conditions: Astrocytoma, Disease Attributes, Glioma, +21 more
Locations: Children's Healthcare of Atlanta Childern Hosp - ATL Atlanta, Georgia, United States

Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. John Hopkins Baltimore, Maryland, United States

Dana Farber Cancer Institute DFCI (3) Boston, Massachusetts, United States

Seattle Children's Hospital CPKC412A2114 Seattle, Washington, United States

View all 14 locations

View Trial Details

Completed

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma

NCT00002601

Conditions: Myosarcoma, Neoplasms, Neoplasms by Histologic Type, +14 more
Locations: Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States

View Trial Details

Completed

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

NCT01005797

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations: Medical University of South Carolina Hollings Cancer Center Charleston, South Carolina, United States

View Trial Details

Completed

Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

NCT01110668

Conditions: Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, +11 more
Locations: Novartis Investigative Site Adana, Turkey (Türkiye)

Novartis Investigative Site Ankara, Turkey (Türkiye)

Novartis Investigative Site Istanbul, Turkey (Türkiye)

Novartis Investigative Site Izmir, Turkey (Türkiye)

View Trial Details

Neoplasms, Connective and Soft Tissue

Neoplasms, Connective and Soft Tissue trial results

Related conditions